Nuance Investments LLC acquired a new stake in Waters Corporation (NYSE:WAT – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 10,762 shares of the medical instruments supplier’s stock, valued at approximately $4,036,000.
Other institutional investors have also recently added to or reduced their stakes in the company. Anchor Investment Management LLC acquired a new stake in Waters in the 1st quarter worth about $27,000. Resources Management Corp CT ADV acquired a new position in shares of Waters during the 1st quarter valued at about $27,000. Zions Bancorporation National Association UT increased its stake in shares of Waters by 121.2% during the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 40 shares during the last quarter. Vision Retirement LLC purchased a new position in shares of Waters during the 1st quarter worth about $29,000. Finally, Bollard Group LLC purchased a new position in shares of Waters during the 1st quarter worth about $29,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.
Waters Trading Down 1.1%
NYSE WAT opened at $407.75 on Tuesday. Waters Corporation has a one year low of $282.77 and a one year high of $420.26. The company’s 50 day moving average price is $378.07 and its 200 day moving average price is $346.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86. The firm has a market capitalization of $40.06 billion, a price-to-earnings ratio of 101.68, a PEG ratio of 2.40 and a beta of 1.19.
Insider Buying and Selling at Waters
In related news, Director Christopher A. Kuebler sold 3,626 shares of Waters stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the transaction, the director owned 17,808 shares in the company, valued at approximately $7,086,515.52. The trade was a 16.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.31% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on WAT shares. UBS Group boosted their target price on shares of Waters from $330.00 to $375.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. Bank of America increased their price target on shares of Waters from $370.00 to $400.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 2nd. Weiss Ratings cut shares of Waters from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, August 12th. TD Cowen upgraded Waters from a “hold” rating to a “buy” rating and upped their price objective for the stock from $408.00 to $475.00 in a report on Wednesday, August 5th. Finally, JPMorgan Chase & Co. increased their target price on Waters from $330.00 to $345.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Three investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $420.35.
Get Our Latest Stock Analysis on Waters
Waters Company Profile
Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.
Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.
Featured Articles
- Five stocks we like better than Waters
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
